Asio Capital LLC Increases Stock Holdings in UnitedHealth Group Incorporated $UNH

Asio Capital LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 31.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 20,440 shares of the healthcare conglomerate’s stock after purchasing an additional 4,841 shares during the quarter. UnitedHealth Group comprises about 1.1% of Asio Capital LLC’s holdings, making the stock its 27th biggest holding. Asio Capital LLC’s holdings in UnitedHealth Group were worth $6,377,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of UNH. Brighton Jones LLC boosted its stake in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. Baker Tilly Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 5.4% in the first quarter. Baker Tilly Wealth Management LLC now owns 1,276 shares of the healthcare conglomerate’s stock valued at $668,000 after purchasing an additional 65 shares during the period. Fiduciary Alliance LLC boosted its stake in shares of UnitedHealth Group by 2.8% in the first quarter. Fiduciary Alliance LLC now owns 10,172 shares of the healthcare conglomerate’s stock valued at $5,328,000 after purchasing an additional 279 shares during the period. Finally, NBC Securities Inc. boosted its stake in shares of UnitedHealth Group by 71,127.3% in the first quarter. NBC Securities Inc. now owns 7,835 shares of the healthcare conglomerate’s stock valued at $4,103,000 after purchasing an additional 7,824 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. Barclays raised their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Bank of America raised their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a report on Monday, August 18th. Finally, Morgan Stanley raised their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $358.95.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $344.61 on Tuesday. The firm’s fifty day moving average price is $302.45 and its 200 day moving average price is $357.73. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market cap of $312.10 billion, a price-to-earnings ratio of 14.93, a price-to-earnings-growth ratio of 2.24 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.